Orlando, FL - 2013 Genitourinary Cancers Symposium - Orlando, FL: Thomas E. Hutson MD discusses Abstract #LBA348 Axitinib versus sorafenib as first?line therapy in patients with metastatic renal cell carcinoma (mRCC) during the Oral Abstract Session C: Renal Cancer at the Genitourinary Cancers Symposium 2013 here today, Saturday February 16, 2013. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, the American Society of Radiation Oncology and SUO, the Society of Urologic Oncology. Over 2,500 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Rosen Shingle Creek in Orlando and features the latest Genitourinary Cancers research in the areas of basic and clinical science. Date: Saturday February 16, 2013. Photo by © ASCO/Todd Buchanan 2013 Technical Questions: firstname.lastname@example.org; Phone: 612-226-5154.